ENALARE THERAPEUTICS
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical care conditions including respiratory depression caused by drug overdose, post-surgery, and pathogens.
ENALARE THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
Naples, Florida, United States
Country:
United States
Website Url:
http://www.enalare.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
23.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Alterome Therapeutics
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Cyclerion Therapeutics
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Employees Featured
Founder
Investors List
Eagle Pharmaceuticals
Eagle Pharmaceuticals investment in Corporate Round - Enalare Therapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Enalare Therapeutics
Official Site Inspections
http://www.enalare.com
- Host name: ec2-3-222-209-23.compute-1.amazonaws.com
- IP address: 3.222.209.23
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Enalare Therapeutics"
Home - Enalare Therapeutics
The Enalare Therapeutics team includes a very experienced management team, Board of Directors, world-renowned scientific advisors, and talented team members that are determined …See details»
Enalare Therapeutics Inc.
Enalare Therapeutics Inc. Developing and commercializing novel therapies for life-threatening acute respiratory and critical care conditions April 2021 ... Organization (CRO) Corporate …See details»
Who We Are - Enalare Therapeutics
Enalare Therapeutics is a privately owned clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory …See details»
Enalare Therapeutics - Crunchbase Company Profile
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients …See details»
Enalare Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Enalare Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 31 news, and 8 literature, Technology Platform:Small molecule drug, Drug:ENA …See details»
Enalare Therapeutics - Funding, Financials, Valuation & Investors
Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies. New. Resources. Advanced Search. Start Free Trial . ... How much funding …See details»
ENALARE THERAPEUTICS LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ENALARE THERAPEUTICS LLC of Naples, FL. Get the latest business insights from Dun & Bradstreet.See details»
Enalare Therapeutics - Contacts, Employees, Board Members, …
Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies. New. Resources. ... Experience the new Crunchbase, powered by AI . …See details»
Enalare - Company Profile - Tracxn
Jan 30, 2025 Enalare. has raised a total funding of $35M over 2 rounds. Its first funding round was on Feb 02, 2021. What are the most recent funding rounds of Enalare? Its latest funding …See details»
Enalare Therapeutics - VentureRadar
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical …See details»
Enalare Therapeutics - Overview, News & Similar companies
Mar 7, 2023 Who is Enalare Therapeutics. Enalare Therapeutics, founded in 2019 and headquartered in Princeton, NJ, is a clinical-stage biopharmaceutical company dedicated to …See details»
Enalare 2025 Company Profile: Valuation, Funding & Investors
When was Enalare founded? Enalare was founded in 2018. Where is Enalare headquartered? Enalare is headquartered in Princeton, NJ. What is the size of Enalare? Enalare has 10 total …See details»
Orphanet: Enalare Therapeutics Inc.
Enalare Therapeutics Inc. Enalare Therapeutics Inc. 161 Hodge Rd. 8540 PRINCETON NJ . UNITED STATES. Phone 1: [email protected] Institution's website Contacts. …See details»
Enalare Therapeutics INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Enalare Therapeutics INC. of Princeton, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Enalare Therapeutics Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Enalare Therapeutics Inc.
Oct 15, 2021 Enalare Therapeutics Inc. Developing Novel Therapies for Life-threatening Critical Care Conditions October 2021 Contact: Daniel Motto, Chief Operating Officer …See details»
Enalare Therapeutics Receives Second Component of a National
Jan 30, 2025 Enalare plans to initiate additional clinical studies for ENA-001 in the near-term. About ENA-001. Enalare’s lead compound, ENA-001, is a one-of-a-kind new chemical entity …See details»
Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical ...
Sep 24, 2024 PRINCETON, NJ / ACCESSWIRE / September 24, 2024 /Enalare Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing novel compounds …See details»
Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical ...
Sep 24, 2024 Enalare plans to initiate additional clinical studies for ENA-001 across multiple indications in the near term. About ENA-001. Enalare's lead compound, ENA-001, is a one-of …See details»
BARDA & Enalare Therapeutics announce partnership to advance …
BARDA and Enalare Therapeutics have partnered to reformulate ENA-001 for use as an emergency treatment against opioid-induced respiratory depression (OIRD). Respiratory …See details»